CN105998495A - 一种治疗烫伤的中药组合物及其制备方法 - Google Patents
一种治疗烫伤的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN105998495A CN105998495A CN201610424548.8A CN201610424548A CN105998495A CN 105998495 A CN105998495 A CN 105998495A CN 201610424548 A CN201610424548 A CN 201610424548A CN 105998495 A CN105998495 A CN 105998495A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- radix
- scalded
- medicinal liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 111
- 239000000203 mixture Substances 0.000 title claims abstract description 108
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 241000628997 Flos Species 0.000 claims abstract description 40
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 21
- 241000283956 Manis Species 0.000 claims abstract description 21
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 239000009286 sanguis draxonis Substances 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 50
- 239000007788 liquid Substances 0.000 claims description 43
- 239000000284 extract Substances 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 235000019864 coconut oil Nutrition 0.000 claims description 12
- 239000003240 coconut oil Substances 0.000 claims description 12
- -1 methyl p-aminobenzoate sodium Chemical compound 0.000 claims description 12
- 229940045870 sodium palmitate Drugs 0.000 claims description 12
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 claims description 12
- 239000002671 adjuvant Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 239000003623 enhancer Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 239000000080 wetting agent Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 5
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 4
- PWVUXRBUUYZMKM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCO PWVUXRBUUYZMKM-UHFFFAOYSA-N 0.000 claims description 4
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 4
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims description 4
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 claims description 4
- 229960005233 cineole Drugs 0.000 claims description 4
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 4
- 229940093471 ethyl oleate Drugs 0.000 claims description 4
- 229960004025 sodium salicylate Drugs 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 20
- 208000002193 Pain Diseases 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 11
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 3
- 208000003455 anaphylaxis Diseases 0.000 abstract description 3
- 240000001866 Vernicia fordii Species 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 208000033809 Suppuration Diseases 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 230000036074 healthy skin Effects 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 206010052428 Wound Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010048768 Dermatosis Diseases 0.000 description 3
- 206010060891 General symptom Diseases 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000349731 Afzelia bipindensis Species 0.000 description 1
- 235000014290 Artemisia anomala Nutrition 0.000 description 1
- 241000123844 Artemisia anomala Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000283967 Manidae Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241000158728 Meliaceae Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000382362 Persicaria tinctoria Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010065954 Stubbornness Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229910001748 carbonate mineral Inorganic materials 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种治疗烫伤的中药组合物及其制备方法,所述中药组合物的由下面原料重量份加工制备而成:地榆、大黄、甘草、刘寄奴、苦楝皮、半夏、冰片、桐子花、青黛、炉甘石、当归、薄荷、地骨皮、红花、血竭,穿山甲、防风。本发明提供的治疗烫伤的中药组合物,采用原料为安全度高的纯植物,该中药组合物配方科学合理,各组分协同作用,疗效显著、安全方便且无毒副作用,不会发生过敏反应,抗菌清热止痛,活血生肌,防止烫伤面积扩大和感染化脓,能有效治疗烫伤,恢复健康皮肤。中药组合物及其制剂的制备方法简单、高效,提取有效成分效果好,适合工业生产。
Description
技术领域
本发明属于医药领域,尤其涉及一种治疗烫伤的中药组合物及其制备方法。
背景技术
近年来皮肤病的发病率呈明显升高趋势,生活环境、饮食、遗传、免疫功能紊乱、精神刺激、外伤感染等多方面因素导致顽固性皮肤病,如化脓性皮肤病,浓疮、风疮、外痈、疮毒、诸毒,疥藓。而久病多瘀,久医伤身,治疗过程因用药不当导致病情恶化的患者比比皆是,并且很多治疗药物都有一定的副作用。长期使用皮质激素类药物、抗癌药与含有重金属类口服药物,致病情趋向顽固恶化很难治愈。
乳腺增生是指乳腺上皮和纤维组织增生,乳腺组织导管和乳小叶在结构上的退行性病变及进行性结缔组织的生长,是女性最常见的乳房疾病,其发病率占乳腺疾病的首位,近些年来该病发病率呈逐年上升的趋势,年龄也越来越低龄化。现有治疗皮肤病、乳腺增生的药物见效慢,刺激性大,治疗效果不理想。
因此,开发一种对多种皮肤病以及乳腺增生具有确切治疗效果的中药组合物,将具有重要的意义和价值。
发明内容
针对上述现有技术中存在的问题与缺陷,本发明的目的在于提供一种治疗烫伤的中药组合物及其制备方法,该组合物疗效显著、安全方便且无毒副作用,其制备方法高效,提取有效成分效果好,适合工业生产。
本发明是以如下的技术方案实现的。
本发明提供一种治疗烫伤的中药组合物,制备所述中药组合物的主要原料重量份组成为:地榆10-25、大黄10-30、甘草20-55、刘寄奴5-21、苦楝皮12-32、半夏21-40、冰片10-30、桐子花25-50、青黛11-33、炉甘石20-45、当归23-53、薄荷12-32、地骨皮10-30、红花20-45、血竭7-32,穿山甲18-36、防风18-35。
优选的,制备所述中药组合物的原料重量份组成为:地榆15-20、大黄10-20、甘草30-55、刘寄奴5-15、苦楝皮18-30、半夏25-35、冰片15-30、桐子花25-42、青黛15-30、炉甘石20-35、当归23-33、薄荷12-22、地骨皮15-30、红花20-40、血竭7-20,穿山甲20-35、防风18-25。
优选的,制备所述中药组合物的原料重量份组成为:地榆16-18、大黄12-20、甘草32-45、刘寄奴7-12、苦楝皮20-25、半夏30-35、冰片17-25、桐子花25-29、青黛15-21、炉甘石20-25、当归27-33、薄荷15-20、地骨皮20-25、红花20-30、血竭10-20,穿山甲22-30、防风18-22。
优选的,制备所述中药组合物的原料重量份组成为:地榆18、大黄15、甘草35、刘寄奴10、苦楝皮23、半夏33、冰片20、桐子花25、青黛18、炉甘石22、当归30、薄荷18、地骨皮20、红花25、血竭15,穿山甲25、防风20。
以上组成中,药的重量是以生药计算的,以重量份作为配比,在生产时可按照比例增大或减少,如大规模生产可以以公斤为单位,或以吨为单位,小规模生产也可以以克或毫克为单位,重量可以增大或者减小,但各组成之间的生药材重量配比的比例不变。且以上重量配比的比例是经过科学筛选得到的,可以相应调整组成的量的配比,增加或减少不超过100%,药效不变。
本发明的治疗烫伤的中药组合物组方科学合理,其中原料药来源如下:地榆:为蔷薇科植物地榆或长叶地榆的干燥根。味苦,微寒,入肝、大肠经,凉血上血,清热解毒,治吐血,衄血,血痢,崩漏,肠风,痔漏,痈肿,湿疹,金疮,烧伤。
大黄 :苦,寒,功效:攻积滞,清湿热,泻火,凉血,祛瘀,解毒。主治 :实热便秘,热结胸痞,湿热泻痢,黄疸,淋病,水肿腹满,小便不利,目赤,咽喉肿痛,口舌生疮,胃热呕吐,吐血,咯血,衄血,便血,尿血,蓄血,经闭,产后瘀滞腹痛,症瘕积聚,跌打损伤,热毒痈疡,丹毒,烫伤。
甘草,来源为豆科植物甘草的根及根状茎。性味甘、平,入脾、胃、肺经,和中缓急,润肺,解毒,调和诸药。
刘寄奴:为菊科植物奇蒿的全草。味苦,性温,入心、脾经。破血通经,敛疮消肿。治经闭症瘕,胸腹胀痛,产后血瘀,跌打损伤,金疮出血,痈毒焮肿。
苦楝皮:为楝科植物川楝或楝的干燥树皮及根皮。味苦,性寒,清热,燥湿,杀虫。治蛔虫,蛲虫,风疹,疥癣。
半夏:为天南星科植物半夏的块茎。味辛,性温,入脾、胃经。燥湿化痰,降逆止呕,消痞散结,治湿痰冷。
冰片 :辛苦,凉,通诸窍,散郁火,去翳明目,消肿止痛。治中风口噤,热病神昏,惊痫。
桐子花:为大戟科植物油桐的花,苦、微辛、寒,入肺、心经,清热解毒;生肌。主新生儿湿疹;秃疮;热毒疮;天沟疮;烧烫伤。
炉甘石:为碳酸盐类矿物菱锌矿的矿石。甘,温,入肝、脾、肺经,去翳退赤,收温敛疮。治目赤翳障,烂弦风眼,溃疡不敛,皮肤湿疮。
青黛:为爵床科植物马蓝、蓼科植物蓼蓝或十字花科植物菘蓝的叶或茎叶经加工制得的干燥粉末或团块。咸,寒,归肝经。清热解毒,凉血,定惊。用于温毒发斑,血热吐衄,胸痛咳血,口疮,痄腮,喉痹,小儿惊痫。
当归 :性温,味甘、辛,功能主治: 补血活血,调经止痛,润肠通便。用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
薄荷:为唇形科薄荷属植物薄荷的干燥地上部分。辛,凉,归肺、肝经,宣散风热。清头目,透疹。用于风热感冒,风温初起,头痛,目赤,喉痹,口疮,风疹,麻疹,胸胁胀闷。
地骨皮:为茄科植物枸杞或宁夏枸杞的干燥根皮。甘,寒,归肺、肝、肾经,凉血除蒸,清肺降火。用于阴虚潮热,骨蒸盗汗,肺热咳嗽,咯血,衄血,内热消渴。
红花:为菊科植物红花的花。辛,温。入心、肝经。活血通经,去瘀止痛。治经闭,症瘕,难产,死胎,产后恶露不行、瘀血作痛,痈肿,跌扑损伤。
血竭 :甘、咸、平,功效:内服活血散瘀,定痛,外用止血生肌,敛疮,淤血经闭,痛经,产后瘀阻,症瘕痞块,胸腹刺痛,跌打损伤,淤血肿痛,外伤出血,溃疡不敛。
穿山甲:为鲮鲤科动物穿穿山甲鳞甲。性味咸,微寒。归肝、胃经。通经下乳,消肿排脓,搜风通络。用于经闭癓瘕,乳汁不通,痈肿疮毒,关节痹痛,麻木拘挛。
防风:味辛、甘,性微温,功效:祛风解表,胜湿止痛,止痉定搐。主治外感表证,风疹瘙痒,风湿痹痛,破伤风。
进一步,本发明提供了一种由治疗烫伤的中药组合物制备的外用药液,所述外用药液包括下列重量份组成的中药组合物、溶剂和辅料:中药组合物20-45、溶剂150-400、透皮促进剂5-7、防腐剂2-6、润湿剂5-8。
所述溶剂为体积分数为55-75%的酒精,所述透皮促进剂包括二乙二醇单硬脂酸、分馏椰子油、油酸乙酯的一种或多种,所述防腐剂包括桉油醇、水杨酸钠、对氨基苯甲酸甲酯钠的一种或多种,所述润湿剂包括甘油、棕榈酸钠、月桂酸异丙醇酰胺的一种或多种。
作为本发明进一步改进,所述溶剂为体积分数为70%的酒精,所述透皮促进剂为分馏椰子油,所述防腐剂为对氨基苯甲酸甲酯钠,所述润湿剂为棕榈酸钠,所述外用药液包括下列重量份组成的中药组合物、溶剂和辅料:中药组合物32、酒精330、分馏椰子油 6、对氨基苯甲酸甲酯钠5、棕榈酸钠7。
进一步,本发明提供了一种外用药液的制备方法,所述制备方法包括:(1)称取处方量的中药组合物,置于体积分数为70%的酒精中,混合均匀,得到中药组合物溶液;(2)向中药组合物溶液加入处方量的分馏椰子油、对氨基苯甲酸甲酯钠和棕榈酸钠,搅拌均匀,即得治疗烫伤的外用药液;(3)将上述外用药液进行灭菌。
进一步,本发明提供一种治疗烫伤的中药组合物的制备方法,所述方法包括如下步骤:a) 称取处方量的防风、当归、苦楝皮和薄荷4味原料药加水煎煮2次,第一次15倍水量煎煮4h,第二次10倍水量煎煮2h,合并得煎液,温度50℃条件下浓缩成相对密度为1.2g/ml,冷却,加75%的乙醇进行醇沉3h,过滤,在55℃下浓缩成相对密度为1.2g/ml,干燥,制得干浸膏1;b) 称取处方量的地榆、大黄、甘草、刘寄奴、半夏、冰片、桐子花、青黛、炉甘石、地骨皮、红花、穿山甲12味原料药,粉碎、碾磨、过筛制成细粉,所述筛网的数目为10-30目,在搅拌均匀后,加入5-10倍60%-85%乙醇的回流提取2次,每次1-2小时,滤过,合并回流液,在50~60℃下干燥,制得干浸膏2;c)合并干浸膏1和干浸膏2,将其粉碎成粉,然后置于槽型混合机内混合30分钟,即得治疗烫伤的中药组合物。
本发明提供了上述治疗烫伤的中药组合物,在制备治疗烫伤的药物中的应用。
本发明的有益效果为:本发明提供的治疗烫伤的中药组合物,采用原料为安全度高的纯植物,该中药组合物配方科学合理,各组分协同作用,疗效显著、安全方便且无毒副作用,不会发生过敏反应,抗菌清热止痛,活血生肌,防止烫伤面积扩大和感染化脓,能有效治疗烫伤,恢复健康皮肤。
中药组合物及其制剂的制备方法简单、高效,提取有效成分效果好,适合工业生产。
具体实施方式
下面结合具体实施例来进一步描述本发明,本发明的优点和特点将会随着描述而更为清楚。但是应理解所述实施例仅是范例性的,不对本发明的范围构成任何限制。本领域技术人员应该理解的是,在不偏离本发明的精神和范围下可以对本发明技术方案的细节和形式进行修改或替换,但这些修改或替换均落入本发明的保护范围。
实施例1: 一种治疗烫伤的中药组合物,制备所述中药组合物的原料重量份组成为:地榆18 g、大黄15 g、甘草35 g、刘寄奴10 g、苦楝皮23 g、半夏33 g、冰片20 g、桐子花25 g、青黛18 g、炉甘石22 g、当归30 g、薄荷18 g、地骨皮20 g、红花25 g、血竭15 g,穿山甲25 g、防风20 g。
其中,治疗烫伤的中药组合物的制备方法,包括如下步骤:a) 称取处方量的防风、当归、苦楝皮和薄荷4味原料药加水煎煮2次,第一次15倍水量煎煮4h,第二次10倍水量煎煮2h,合并得煎液,温度50℃条件下浓缩成相对密度为1.2g/ml,冷却,加75%的乙醇进行醇沉3h,过滤,在55℃下浓缩成相对密度为1.2g/ml,干燥,制得干浸膏1;b) 称取处方量的地榆、大黄、甘草、刘寄奴、半夏、冰片、桐子花、青黛、炉甘石、地骨皮、红花、穿山甲12味原料药,粉碎、碾磨、过筛制成细粉,所述筛网的数目为10-30目,在搅拌均匀后,加入5-10倍60%-85%乙醇的回流提取2次,每次1-2小时,滤过,合并回流液,在50~60℃下干燥,制得干浸膏2;c)合并干浸膏1和干浸膏2,将其粉碎成粉,然后置于槽型混合机内混合30分钟,即得治疗烫伤的中药组合物。
实施例2:一种治疗烫伤的中药组合物,制备所述中药组合物的主要原料重量份组成为:地榆16g、大黄12g、甘草32g、刘寄奴7g、苦楝皮20g、半夏30g、冰片17g、桐子花25g、青黛15g、炉甘石20g、当归27g、薄荷15g、地骨皮20g、红花20g、血竭10g,穿山甲22g、防风18g。
其中,所述治疗烫伤的中药组合物的制备方法,和实施例1相同。
实施例3 :一种治疗烫伤的中药组合物,制备所述中药组合物的主要原料重量份组成为:地榆18g、大黄20g、甘草45g、刘寄奴12g、苦楝皮25g、半夏35g、冰片25g、桐子花29g、青黛21g、炉甘石25g、当归33g、薄荷20g、地骨皮25g、红花30g、血竭20g,穿山甲30g、防风22g。
其中,所述治疗烫伤的中药组合物的制备方法,和实施例1相同。
实施例4 :一种治疗烫伤的中药组合物,制备所述中药组合物的主要原料重量份组成为:地榆15g、大黄10g、甘草30g、刘寄奴5g、苦楝皮18g、半夏25g、冰片15g、桐子花25g、青黛15g、炉甘石20g、当归23g、薄荷12g、地骨皮15g、红花20g、血竭7g,穿山甲20g、防风18g。
其中,所述治疗烫伤的中药组合物的制备方法,和实施例1相同。
实施例5 :一种治疗烫伤的中药组合物,制备所述中药组合物的主要原料重量份组成为:地榆20g、大黄20g、甘草55g、刘寄奴15g、苦楝皮30g、半夏35g、冰片30g、桐子花42g、青黛30g、炉甘石35g、当归33g、薄荷22g、地骨皮30g、红花40g、血竭20g,穿山甲35g、防风25g。
其中,所述治疗烫伤的中药组合物的制备方法,和实施例1相同。
实施例6 :一种治疗烫伤的中药组合物,制备所述中药组合物的主要原料重量份组成为:地榆10g、大黄10g、甘草20g、刘寄奴5g、苦楝皮12g、半夏21g、冰片10g、桐子花25g、青黛11g、炉甘石20g、当归23g、薄荷12g、地骨皮10g、红花20g、血竭7g,穿山甲18g、防风18g。
其中,所述治疗烫伤的中药组合物的制备方法,和实施例1相同。
实施例7 :一种治疗烫伤的中药组合物,制备所述中药组合物的主要原料重量份组成为:地榆25g、大黄30g、甘草55g、刘寄奴21g、苦楝皮32g、半夏40g、冰片30g、桐子花50g、青黛33g、炉甘石45g、当归53g、薄荷32g、地骨皮30g、红花45g、血竭32g,穿山甲36g、防风35g。
其中,所述治疗烫伤的中药组合物的制备方法,和实施例1相同。
实施例8 :外用药液,一种外用药液包括下列重量份组成的中药组合物、溶剂和辅料:实施例1的中药组合物:32g酒精330g、分馏椰子油6g、对氨基苯甲酸甲酯钠5g、棕榈酸钠7g。
其中,外用药液的制备方法包括:(1)称取处方量的中药组合物,置于体积分数为70%的酒精中,混合均匀,得到中药组合物溶液;(2)向中药组合物溶液加入处方量的分馏椰子油、对氨基苯甲酸甲酯钠和棕榈酸钠,搅拌均匀,即得治疗烫伤的外用药液;(3)将上述外用药液进行灭菌。
实施例9 :外用药液,一种外用药液包括下列重量份组成的中药组合物、溶剂和辅料:实施例1的中药组合物:20g、酒精150g、分馏椰子油5g、对氨基苯甲酸甲酯钠2g、棕榈酸钠5g。
其中,外用药液的制备方法如实施例8。
实施例10 :一种外用药液包括下列重量份组成的中药组合物、溶剂和辅料:实施例1的中药组合物:45g、酒精400g、分馏椰子油7g、对氨基苯甲酸甲酯钠6g、棕榈酸钠8g。
其中,外用药液的制备方法如实施例8。
实施例11 :外用药,一种外用药液包括下列重量份组成的中药组合物、溶剂和辅料:实施例1的中药组合物:20g、酒精150g、二乙二醇单硬脂酸5g、桉油醇2g、甘油5g。
其中,其中,外用药液的制备方法包括:(1)称取处方量的中药组合物,置于体积分数为70%的酒精中,混合均匀,得到中药组合物溶液;(2)向中药组合物溶液加入处方量的二乙二醇单硬脂酸、桉油醇和甘油,搅拌均匀,即得治疗烫伤的外用药液;(3)将上述外用药液进行灭菌。
实施例12 :外用药液,一种外用药液包括下列重量份组成的中药组合物、溶剂和辅料:实施例1的中药组合物:20g、酒精150g、油酸乙酯5g、水杨酸钠2g、月桂酸异丙醇酰胺5g。
其中,其中,外用药液的制备方法包括:(1)称取处方量的中药组合物,置于体积分数为70%的酒精中,混合均匀,得到中药组合物溶液;(2)向中药组合物溶液加入处方量的油酸乙酯、水杨酸钠和月桂酸异丙醇酰胺,搅拌均匀,即得治疗烫伤的外用药液;(3)将上述外用药液进行灭菌。
试验例1 治疗烫伤的效果评价试验。
本发明的治疗烫伤的中药组合物效果如下:1. 病例选择:治疗组50例,年龄25~50岁,平均30岁,病程1-2个月;对照组50例,年龄25~50岁,平均30岁,病程1-2个月。
诊断标准:皮肤进过热水和热汽烫伤后,烫伤部位疼痛、红肿、起水泡。
2. 给药方式:治疗组:使用本发明的治疗烫伤的中药组合物制备的外用药液,用生理盐水对烫伤部位进行清洗后,用棉棒蘸取本发明实施例8的外用药液涂抹,每日2次,3天为1个疗程,连续使用2个疗程。
对照组:通化茂祥制药有限公司的茂祥烧烫伤膏(獾油、地榆、大黄、冰片、虫白蜡,蜂蜡,辅料为茉莉香精,白凡士林),涂敷患处,每日2次,3天为一个疗程,连续使用2个疗程。
3. 疗效标准:治愈 :全身症状消失,创面恢复正常 ;好转 :全身症状消失,创面未完全愈合 ;未愈 :全身症状未见改善,创面感染不能控制。
表4治疗组和对照组的疗效比较
治疗组和对照组比较具有显著差异(P<0.01)。
其中,治疗组,治疗 50例,临床治愈 42 例 (84% ),好转48 例 (98% ),无效 1 例 (2% )。
6. 效果判定:本发明的治疗烫伤的中药组合物及由其制得的外用药液,对烫伤有很好的治疗效果,并且治疗组的治疗效果优于对照组,对烫伤一般2个疗程就能治好,有效率98%、痊愈率84%。
典型病例1:商某,女,28 岁,湖南某师范大学学生。于 2005 年被开水烫伤,由于处理不当导致日后起泡、伤口长期溃烂、流水不止,涂擦本发明的治疗烫伤的中药组合物制备的外用药液后,2日后结壳,10 天后伤口痊愈,继续使用一周后,未留下疤痕,皮肤未变色。
典型病例2:于某,女,35岁,北京一国企在职员工。在做饭时被油烫伤后,去诊所治疗效果不好,经人介绍使用本发明的治疗烫伤的中药组合物制备的外用药液后,止血止痛,未起泡、皮肤未变色,经过10天后,伤口完全愈合,没有留下疤痕。
Claims (8)
1.一种治疗烫伤的中药组合物,其特征在于,制备所述中药组合物的主要原料重量份组成为:地榆10-25、大黄10-30、甘草20-55、刘寄奴5-21、苦楝皮12-32、半夏21-40、冰片10-30、桐子花25-50、青黛11-33、炉甘石20-45、当归23-53、薄荷12-32、地骨皮10-30、红花20-45、血竭7-32,穿山甲18-36、防风18-35。
2.根据权利要求1所述的治疗烫伤的中药组合物,其特征在于,制备所述中药组合物的原料重量份组成为:地榆15-20、大黄10-20、甘草30-55、刘寄奴5-15、苦楝皮18-30、半夏25-35、冰片15-30、桐子花25-42、青黛15-30、炉甘石20-35、当归23-33、薄荷12-22、地骨皮15-30、红花20-40、血竭7-20,穿山甲20-35、防风18-25。
3.根据权利要求2所述的治疗烫伤的中药组合物,其特征在于,制备所述中药组合物的原料重量份组成为:地榆16-18、大黄12-20、甘草32-45、刘寄奴7-12、苦楝皮20-25、半夏30-35、冰片17-25、桐子花25-29、青黛15-21、炉甘石20-25、当归27-33、薄荷15-20、地骨皮20-25、红花20-30、血竭10-20,穿山甲22-30、防风18-22。
4.根据权利要求3所述的治疗烫伤的中药组合物,其特征在于,制备所述中药组合物的原料重量份组成为:地榆18、大黄15、甘草35、刘寄奴10、苦楝皮23、半夏33、冰片20、桐子花25、青黛18、炉甘石22、当归30、薄荷18、地骨皮20、红花25、血竭15,穿山甲25、防风20。
5.由权利要求1-4中任一项所述治疗烫伤的中药组合物制备的外用药液,其特征在于,所述外用药液包括下列重量份组成的中药组合物、溶剂和辅料:中药组合物 20-45、溶剂150-400、透皮促进剂5-7、防腐剂2-6、润湿剂5-8;所述溶剂为体积分数为55-75%的酒精,所述透皮促进剂包括二乙二醇单硬脂酸、分馏椰子油、油酸乙酯的一种或多种,所述防腐剂包括桉油醇、水杨酸钠、对氨基苯甲酸甲酯钠的一种或多种,所述润湿剂包括甘油、棕榈酸钠、月桂酸异丙醇酰胺的一种或多种。
6.根据权利要求5所述的由治疗烫伤的中药组合物制备的外用药液,其特征在于,所述溶剂为体积分数为70%的酒精,所述透皮促进剂为分馏椰子油,所述防腐剂为对氨基苯甲酸甲酯钠,所述润湿剂为棕榈酸钠,所述外用药液包括下列重量份组成的中药组合物、溶剂和辅料:中药组合物32、酒精330、分馏椰子油6、对氨基苯甲酸甲酯钠5、棕榈酸钠7。
7.一种权利要求6中任一项所述的外用药液的制备方法,其特征在于,所述方法包括:(1)称取处方量的中药组合物,置于体积分数为70%的酒精中,混合均匀,得到中药组合物溶液;(2)向中药组合物溶液加入处方量的分馏椰子油、对氨基苯甲酸甲酯钠和棕榈酸钠,搅拌均匀,即得治疗烫伤的外用药液;(3)将上述外用药液进行灭菌。
8.一种权利要求1-4中任一项所述的治疗烫伤的中药组合物的制备方法,其特征在于,所述方法包括如下步骤:a) 称取处方量的防风、当归、苦楝皮和薄荷4味原料药加水煎煮2次,第一次15倍水量煎煮4h,第二次10倍水量煎煮2h,合并得煎液,温度50℃条件下浓缩成相对密度为1.2g/ml,冷却,加75%的乙醇进行醇沉3h,过滤,在55℃下浓缩成相对密度为1.2g/ml,干燥,制得干浸膏1;b) 称取处方量的地榆、大黄、甘草、刘寄奴、半夏、冰片、桐子花、青黛、炉甘石、地骨皮、红花、穿山甲12味原料药,粉碎、碾磨、过筛制成细粉,所述筛网的数目为10-30目,在搅拌均匀后,加入5-10倍60%-85%乙醇的回流提取2次,每次1-2小时,滤过,合并回流液,在50~60℃下干燥,制得干浸膏2;c)合并干浸膏1和干浸膏2,将其粉碎成粉,然后置于槽型混合机内混合30分钟,即得治疗烫伤的中药组合物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610424548.8A CN105998495A (zh) | 2016-06-16 | 2016-06-16 | 一种治疗烫伤的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610424548.8A CN105998495A (zh) | 2016-06-16 | 2016-06-16 | 一种治疗烫伤的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105998495A true CN105998495A (zh) | 2016-10-12 |
Family
ID=57087678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610424548.8A Pending CN105998495A (zh) | 2016-06-16 | 2016-06-16 | 一种治疗烫伤的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105998495A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106668839A (zh) * | 2017-02-24 | 2017-05-17 | 刘海宾 | 一种用于止血镇痛的中西药组合物及其制备工艺 |
CN108434306A (zh) * | 2018-06-26 | 2018-08-24 | 张宗杰 | 一种普外科烧烫伤治疗中药组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104623161A (zh) * | 2013-11-11 | 2015-05-20 | 李耀华 | 一种治疗烧烫伤的中药组合物 |
-
2016
- 2016-06-16 CN CN201610424548.8A patent/CN105998495A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104623161A (zh) * | 2013-11-11 | 2015-05-20 | 李耀华 | 一种治疗烧烫伤的中药组合物 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106668839A (zh) * | 2017-02-24 | 2017-05-17 | 刘海宾 | 一种用于止血镇痛的中西药组合物及其制备工艺 |
CN108434306A (zh) * | 2018-06-26 | 2018-08-24 | 张宗杰 | 一种普外科烧烫伤治疗中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579918A (zh) | 治疗青光眼的中药组合物、制备方法及给药方式 | |
CN104338083A (zh) | 一种治疗月经不调的药物及其制备方法 | |
CN103463297B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法和用途 | |
CN104826036A (zh) | 一种治疗乳腺增生的复合中药组合物及制备方法 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN103920034A (zh) | 减轻肿瘤病人化疗副反应的中药组合物及制法 | |
CN104173517B (zh) | 治疗原发性三叉神经痛的中药制剂及制备方法 | |
CN102626505A (zh) | 基于中草药的按摩膏及其制备方法 | |
CN105998495A (zh) | 一种治疗烫伤的中药组合物及其制备方法 | |
CN101417087B (zh) | 一种治疗妇科产后疾病的药物及其制备方法 | |
CN105999105A (zh) | 一种治疗褥疮和糖尿病溃烂的中药组合物及其制备方法 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN106361932A (zh) | 一种用于跌打损伤的外擦中药酊剂 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN103610772A (zh) | 治疗脑血栓的中药 | |
CN112237621B (zh) | 一种用于乳腺增生的中药乳膏及其制备方法 | |
CN103690816B (zh) | 消除脾虚痰湿乳房囊性增生的中药组合物及其制备方法 | |
CN105456951A (zh) | 一种治疗乳房纤维腺瘤的中药制剂及其制备方法 | |
CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
CN104888148A (zh) | 一种治疗慢性乙型肝炎的药物 | |
CN105012789A (zh) | 治疗宫颈癌的组合物及其制备方法 | |
CN104474452A (zh) | 一种治疗血凝蕴毒型褥疮的药物及其制备方法 | |
CN117338858A (zh) | 一种祛疤膏及其制备方法 | |
CN104436043A (zh) | 一种治疗疮疡阳证的止痛消炎药膏及其制备方法 | |
CN113797302A (zh) | 一种治疗自然流产的中药组合物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161012 |
|
WD01 | Invention patent application deemed withdrawn after publication |